Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Feb 22, 2017 (10 years ago)

Fluocinolone Acetonide Topical Solution USP 0.01% For Topical Use Only

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Chemical Contamination

Cause type: Chemical / undeclared

A chemical that should not be there - benzene, methanol, lead - or an undeclared prescription drug hidden in a supplement. The label gives no warning: you may be taking a toxic solvent, a heavy metal, or a drug such as sildenafil that interacts with your other medicines. All chemical / undeclared recalls.

What was recalled

Fluocinolone Acetonide Topical Solution USP 0.01% For Topical Use Only, Not for Ophthalmic Use, 60 mL bottle, Rx Only, Manufactured for Gavis Pharmaceuticals, LLC, Somerset NJ 08873, Manufactured by Novel Laboratories, Inc. Somerset, NJ 08873, NDC 43386-069-60

Affected NDC 43386-0069-60

Compare with the code on your package — it is the most precise check available.

Drug: Fluocinolone Category: Eye Drops & Ophthalmic

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Fluocinolone Acetonide
NDC 43386-0069
.1 mg/mL Solution
Topical
Lupin Pharmaceuticals,Inc. Rx
Recalling firm
Novel Laboratories, Inc.
NDC code
43386-069-60
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0653-2017 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Fluocinolone recalls

See all
Class II · Moderate risk

Fluocinolone Acetonide Oil

Failed Excipient Specifications: OOS for assay of Isopropyl Alcohol

Terminated Failed specification Glenmark Pharmaceuticals Inc., USA NDC 68462-185-56 D-0259-2024
Class II · Moderate risk

DermOtic Oil

Presence of Foreign Substance: Potential for broken glass within the glass pipette of the dropper.

Terminated Particulate / foreign matter Hill Dermaceuticals, Inc. NDC 68791-103-20 D-0637-2021
Class II · Moderate risk

Formula 82M

Lack of Processing Controls (lack of assurance of conformity to specifications).

Terminated cGMP deviation MasterPharm LLC D-1424-2020
Class II · Moderate risk

Formula 82F

Lack of Processing Controls (lack of assurance of conformity to specifications).

Terminated cGMP deviation MasterPharm LLC D-1423-2020

Other recalls by Novel Laboratories, Inc.

All 2017 recalls
Class III · Low risk

Peg-3350

Defective container: potential for non-sealed pouches which can lead to product leakage.

Terminated Packaging defect Novel Laboratories, Inc. d.b.a Lupin Somerset NDC 0093-3560-26 D-0628-2024
Class II · Moderate risk

GaviLyteTM - C PEG-3350

Failed Stability Specification; Out of specification for Osmolarity

Terminated Stability / shelf life Novel Laboratories, Inc. d.b.a LUPIN NDC 43386-060-19 D-0726-2021